Hunan Hansen Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Hunan Hansen Pharmaceutical Co Ltd cash flow reinvestment rate. Hunan Hansen Pharmaceutical Co Ltd (002412) has a Cash Flow Reinvestment Rate of 0.07x as of September 2025, reinvesting CN¥3.82 Million (capex CN¥3.82 Million ) from operating cash flow of CN¥52.51 Million. Explore 002412 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Hunan Hansen Pharmaceutical Co Ltd (2007–2025)
Cash flow reinvestment rate of Hunan Hansen Pharmaceutical Co Ltd from 2007 to 2025. Historical reinvestment intensity for Hunan Hansen Pharmaceutical Co Ltd across 19 annual periods. Explore Hunan Hansen Pharmaceutical Co Ltd (002412) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Hunan Hansen Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2007–2025)
Hunan Hansen Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2007 to 2025. Year-by-year capital reinvestment analysis for Hunan Hansen Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 002412 cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.38x | CN¥93.86 Million | CN¥245.38 Million | CN¥11.10 Million | ▲ +48.6% |
| 2024 | 0.26x | CN¥33.67 Million | CN¥130.78 Million | CN¥11.64 Million | ▼ -37.8% |
| 2023 | 0.41x | CN¥66.58 Million | CN¥160.95 Million | CN¥19.48 Million | ▼ -44.7% |
| 2022 | 0.75x | CN¥107.57 Million | CN¥143.81 Million | CN¥11.50 Million | ▼ -42.8% |
| 2021 | 1.31x | CN¥278.17 Million | CN¥212.54 Million | CN¥229.34 Million | ▲ +52.9% |
| 2020 | 0.86x | CN¥138.85 Million | CN¥162.19 Million | CN¥129.08 Million | ▲ +153.7% |
| 2019 | 0.34x | CN¥55.71 Million | CN¥165.11 Million | CN¥35.71 Million | ▼ -42.5% |
| 2018 | 0.59x | CN¥127.73 Million | CN¥217.52 Million | CN¥64.53 Million | ▼ -44.5% |
| 2017 | 1.06x | CN¥113.40 Million | CN¥107.18 Million | CN¥50.20 Million | ▼ -63.0% |
| 2016 | 2.86x | CN¥460.81 Million | CN¥161.16 Million | CN¥44.91 Million | ▲ +64.0% |
| 2015 | 1.74x | CN¥110.83 Million | CN¥63.57 Million | CN¥75.89 Million | ▲ +101.0% |
| 2014 | 0.87x | CN¥73.75 Million | CN¥85.05 Million | CN¥73.75 Million | ▼ -39.1% |
| 2013 | 1.43x | CN¥108.44 Million | CN¥76.09 Million | CN¥108.44 Million | ▲ +19.2% |
| 2012 | 1.20x | CN¥119.87 Million | CN¥100.23 Million | CN¥119.87 Million | ▲ +69.9% |
| 2011 | 0.70x | CN¥37.90 Million | CN¥53.84 Million | CN¥37.90 Million | ▲ +318.6% |
| 2010 | 0.17x | CN¥3.57 Million | CN¥21.24 Million | CN¥3.57 Million | ▼ -66.4% |
| 2009 | 0.50x | CN¥20.55 Million | CN¥41.02 Million | CN¥20.55 Million | ▲ +30.4% |
| 2008 | 0.38x | CN¥13.04 Million | CN¥33.94 Million | CN¥13.04 Million | ▼ -15.6% |
| 2007 | 0.46x | CN¥17.18 Million | CN¥37.75 Million | CN¥17.18 Million | — |